Emulate to qualify Organs-on-Chips as toxicology testing platforms


In Massachusetts, Emulate, Inc. entered into a Cooperative Research and Development Agreement with the U.S. Food and Drug Administration’s Office of Foods and Veterinary Medicine to evaluate and qualify the use of Emulate’s Organs-on-Chips technology as a platform for toxicology testing to meet regulatory evaluation criteria for products – including foods, dietary supplements and cosmetics.

Each of Emulate’s proprietary Organs-on-Chips – such as the lung, liver, brain or kidney – is a living, micro-engineered environment that recreates the natural physiology and mechanical forces that cells experience within the human body. Containing tiny hollow channels lined with tens of thousands of living human cells and tissues, an Organ-Chip is approximately the size of an AA battery.

Emulate created a Human Emulation System with Organ-Chips as a predictive model of human response to diseases, medicines, chemicals and foods with greater precision and detail than other preclinical testing methods, such as cell culture or animal-based testing.